SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BERNARDI, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.664
EU - Europa 8.296
AS - Asia 7.602
SA - Sud America 1.182
AF - Africa 97
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 16
Totale 43.889
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.416
SG - Singapore 2.984
CN - Cina 2.821
DE - Germania 1.960
UA - Ucraina 1.717
IT - Italia 1.517
BR - Brasile 1.091
TR - Turchia 1.049
GB - Regno Unito 778
FI - Finlandia 584
PL - Polonia 436
SE - Svezia 434
RU - Federazione Russa 234
CA - Canada 164
ID - Indonesia 152
FR - Francia 144
HK - Hong Kong 112
IN - India 106
BE - Belgio 103
NL - Olanda 94
VN - Vietnam 76
CZ - Repubblica Ceca 63
MX - Messico 53
BD - Bangladesh 45
AT - Austria 43
ZA - Sudafrica 41
ES - Italia 40
JP - Giappone 40
IR - Iran 37
IQ - Iraq 28
AU - Australia 26
LT - Lituania 26
UZ - Uzbekistan 23
AR - Argentina 21
CH - Svizzera 20
IE - Irlanda 18
RO - Romania 16
CO - Colombia 15
PK - Pakistan 14
EC - Ecuador 13
JO - Giordania 13
EU - Europa 12
IL - Israele 12
KR - Corea 12
GR - Grecia 11
KE - Kenya 11
MA - Marocco 11
PT - Portogallo 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 10
AL - Albania 10
JM - Giamaica 9
PE - Perù 9
SA - Arabia Saudita 9
TW - Taiwan 9
DZ - Algeria 8
TN - Tunisia 8
EG - Egitto 7
GE - Georgia 7
BG - Bulgaria 6
CL - Cile 6
DK - Danimarca 6
NZ - Nuova Zelanda 6
OM - Oman 6
PY - Paraguay 6
UY - Uruguay 6
HN - Honduras 5
HU - Ungheria 5
NO - Norvegia 5
NP - Nepal 5
TH - Thailandia 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
LB - Libano 3
LK - Sri Lanka 3
LU - Lussemburgo 3
PS - Palestinian Territory 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GT - Guatemala 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
Totale 43.876
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.988
Fairfield 2.928
Chandler 1.929
Houston 1.874
Jacksonville 1.835
Ashburn 1.480
Santa Clara 1.480
Ann Arbor 1.407
Singapore 1.401
Seattle 1.184
Wilmington 1.105
Cambridge 962
Beijing 693
Izmir 629
Nanjing 571
Ferrara 511
Munich 511
Princeton 437
Warsaw 427
Boardman 396
New York 369
San Diego 270
Milan 200
Shanghai 197
The Dalles 175
Dearborn 173
Nanchang 172
Shenyang 169
Los Angeles 168
Bremen 162
Jakarta 145
Helsinki 142
Hebei 120
Jiaxing 110
Tianjin 105
Falls Church 104
London 97
Hong Kong 95
Brussels 94
Changsha 91
Turku 89
Redwood City 86
Jinan 81
São Paulo 81
Toronto 75
Norwalk 72
San Mateo 71
Kunming 67
Mountain View 65
Düsseldorf 57
Frankfurt am Main 55
Rome 52
Chicago 51
Falkenstein 51
Auburn Hills 49
Brno 48
Zhengzhou 46
Dong Ket 44
Addison 42
Brooklyn 41
Des Moines 41
Guangzhou 38
Nuremberg 38
Ningbo 37
San Francisco 36
Belo Horizonte 35
Rio de Janeiro 35
Columbus 34
Bologna 32
Orange 31
Curitiba 30
Ottawa 29
Hangzhou 27
Taizhou 27
Tokyo 27
Verona 27
Washington 27
Philadelphia 25
Augusta 23
Leawood 21
Mexico City 21
Atlanta 20
Padova 20
Tashkent 20
Dallas 19
Indiana 19
Monmouth Junction 19
Brasília 18
Redmond 18
Boston 17
Florence 17
Amsterdam 16
Chennai 16
Moscow 16
Paris 16
Vienna 16
Ardabil 15
Fuzhou 15
Montreal 15
Porto Alegre 15
Totale 30.097
Salva come PNG Salva come JPEG
Nome #
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 329
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 235
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 231
AN EXON-SPECIFIC U1 SMALL NUCLEAR RNA (snRNA) STRATEGY TO CORRECT SPLICING MUTATIONS ASSOCIATED TO HEMOPHILIA B 216
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 214
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 213
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 208
An exon-specific U1snRNA induces a robust factor IX activity in mice expressing multiple human FIX splicing mutants 206
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides 200
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 197
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 182
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family 180
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 180
Hemostasis biomarkers in multiple sclerosis 179
Moderate alcohol intake and hemostatic and inflammatory markers in middle-aged women: a controlled study 173
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 172
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 170
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 169
Analisi dei multimeri del fattore von Willebrand mediante doppia immunoprecipitazione dopo elettroforesi su gel di agarosio. 169
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 163
High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus? 162
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 161
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 160
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 159
Psychiatric disorder in a familial 15;18 translocation and sublocalization of myelin basic protein of 18q22.3 159
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 158
Chronic sleep deprivation markedly reduces coagulation factor VII expression 158
Characterization of a deleted Y chromosome in a male with Turner stigmata 158
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease. 157
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 157
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 157
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 157
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 151
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 150
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 149
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects 149
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 149
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 149
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 148
A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates. 148
The dominant-negative von Willebrand factor gene deletion p.P1127-C1948delinsR: Molecular mechanism and modulation 148
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 147
A NEW DISEASE-CAUSING MUTATION IN THE GAP-RELATED DOMAIN OF THE NF1 GENE 143
Attività sulla emostasi di alcune piante della medicina tradizionale indiana 143
Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant 143
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 142
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 142
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 141
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 140
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 140
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 138
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 138
Plasma levels of soluble NCAM in multiple sclerosis 138
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 138
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 138
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 137
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 137
Taqi polymorphism at the human coagulation factor XII locus (F12) 136
PvuII RFLP inside the human estrogen receptor gene 136
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 136
Circadian rhythms in mouse blood coagulation 134
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 134
Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity 134
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 134
Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations 133
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 133
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype 132
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 132
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 132
Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency 131
A unique exon specific U1snRNA rescues different haemophilia B - causing splicing-defective factor IX variants in mice 131
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 130
Better or worse than the original 130
Temporal variations of coagulation factor VII activity in mice are influenced by lighting regime 129
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 129
Partial gene deletion in a family with factor X deficiency 129
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 129
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease 128
Membrane binding and anticoagulant properties of protein S natural variants 128
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 128
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 128
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 128
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 127
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 127
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 127
2 TAQI RFLPS IN THE HUMAN VONWILLEBRAND-FACTOR GENE 127
An underestimated combination of opposites resulting in enhanced thrombotic tendency 126
Residual factor VII activity and different hemorrhagic phenotypes in CRM+ factor VII deficiencies (Gly331Ser and Gly283Ser) 126
Factor IX propeptide mutation and life threatening bleeding 126
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 126
null 125
A new factor V gene polymorphism (His 1254 Arg) present in subjects of African origin mimics the R2 polymorphism (His 1299 Arg) 125
Major differences in bleeding symptoms between factor VII deficiency and hemophilia B 124
2 ADDITIONAL TAQI RFLPS IN VONWILLEBRAND-FACTOR GENE (VWF) AND PSEUDOGENE 124
c-myc oncogene alterations in human thyroid carcinomas. 124
Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia 123
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 123
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 123
Evidence for an overlapping role of clock and npas2 transcription factors in liver circadian oscillators 123
Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity 123
Totale 15.008
Salva come PNG Salva come JPEG
Categoria #
all - tutte 229.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.441
Totale 231.435
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.461 458 420 291 642 185 500 331 627 180 801 735 291
2021/20224.434 245 482 276 246 261 178 206 211 138 344 391 1.456
2022/20234.440 488 342 109 583 726 661 211 356 543 39 244 138
2023/20242.348 203 277 110 81 166 433 65 154 59 56 64 680
2024/20259.468 266 186 817 272 1.175 920 242 468 1.492 1.197 1.356 1.077
2025/2026852 852 0 0 0 0 0 0 0 0 0 0 0
Totale 44.590